Know Cancer

or
forgot password


N/A
18 Years
N/A
Not Enrolling
Both
Soft Tissue Sarcoma (STS)

Thank you

Trial Information


Inclusion Criteria:



- Patients with advanced Soft Tissue Sarcoma prior to pazopanib treatment

Exclusion Criteria:

- Other treatment

- FDG negative tumor

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Measure of extent and intensity (standardized uptake value - SUV) of disease demonstrated on PET/CT images before and after treatment.

Outcome Time Frame:

1 week

Authority:

Israel: Ministry of Health

Study ID:

0103-12-HMO

NCT ID:

NCT01594203

Start Date:

May 2012

Completion Date:

May 2013

Related Keywords:

  • Soft Tissue Sarcoma (STS)
  • Soft Tissue Sarcoma
  • Pazopanib
  • F18-FDG PET/CT
  • Sarcoma

Name

Location